A preclinical murine model of hepatic metastases
- PMID: 25285458
- PMCID: PMC4378377
- DOI: 10.3791/51677
A preclinical murine model of hepatic metastases
Abstract
Numerous murine models have been developed to study human cancers and advance the understanding of cancer treatment and development. Here, a preclinical, murine pancreatic tumor model of hepatic metastases via a hemispleen injection of syngeneic murine pancreatic tumor cells is described. This model mimics many of the clinical conditions in patients with metastatic disease to the liver. Mice consistently develop metastases in the liver allowing for investigation of the metastatic process, experimental therapy testing, and tumor immunology research.
References
-
- American Cancer Society. Cancer Facts & Figures. Atlanta: American Cancer Society; 2013.
-
- Clark CE, Beatty GL, Vonderheide RH. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. Cancer letters. 2009;279:1–7. - PubMed
-
- Frese KK, Tuveson DA. Maximizing mouse cancer models. Nature reviews. Cancer. 2007;7:645–658. - PubMed
-
- Corbett TH, et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer research. 1984;44:717–726. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical